EFNA4 Gene

EFNA4 Gene

<div class="infobox infobox-gene">
<table>
<tr><th colspan="2" style="background:#f0f0f0;">EFNA4</th></tr>
<tr><td><b>Gene Symbol</b></td><td>EFNA4</td></tr>
<tr><td><b>Full Name</b></td><td>Ephrin A4</td></tr>
<tr><td><b>Chromosomal Location</b></td><td>1q21.3</td></tr>
<tr><td><b>NCBI Gene ID</b></td><td>[1945](https://www.ncbi.nlm.nih.gov/gene/1945)</td></tr>
<tr><td><b>OMIM ID</b></td><td>[602020](https://www.omim.org/entry/602020)</td></tr>
<tr><td><b>Ensembl ID</b></td><td>[ENSG00000126247](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000126247)</td></tr>
<tr><td><b>UniProt ID</b></td><td>[P52802](https://www.uniprot.org/uniprotkb/P52802/entry)</td></tr>
<tr><td><b>Protein Name</b></td><td>Ephrin-A4 (EFNA4)</td></tr>
<tr><td><b>Associated Diseases</b></td><td>[Alzheimer's Disease](/diseases/alzheimers-disease), [Parkinson's Disease](/diseases/parkinsons-disease), [Autism Spectrum Disorder](/diseases/autism), [Epilepsy](/diseases/epilepsy)</td></tr>
</table>
</div>

Overview

EFNA4 Gene

<div class="infobox infobox-gene">
<table>
<tr><th colspan="2" style="background:#f0f0f0;">EFNA4</th></tr>
<tr><td><b>Gene Symbol</b></td><td>EFNA4</td></tr>
<tr><td><b>Full Name</b></td><td>Ephrin A4</td></tr>
<tr><td><b>Chromosomal Location</b></td><td>1q21.3</td></tr>
<tr><td><b>NCBI Gene ID</b></td><td>[1945](https://www.ncbi.nlm.nih.gov/gene/1945)</td></tr>
<tr><td><b>OMIM ID</b></td><td>[602020](https://www.omim.org/entry/602020)</td></tr>
<tr><td><b>Ensembl ID</b></td><td>[ENSG00000126247](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000126247)</td></tr>
<tr><td><b>UniProt ID</b></td><td>[P52802](https://www.uniprot.org/uniprotkb/P52802/entry)</td></tr>
<tr><td><b>Protein Name</b></td><td>Ephrin-A4 (EFNA4)</td></tr>
<tr><td><b>Associated Diseases</b></td><td>[Alzheimer's Disease](/diseases/alzheimers-disease), [Parkinson's Disease](/diseases/parkinsons-disease), [Autism Spectrum Disorder](/diseases/autism), [Epilepsy](/diseases/epilepsy)</td></tr>
</table>
</div>

Overview

EFNA4 (Ephrin A4) is a member of the ephrin family of cell surface proteins that function as ligands for EPHA receptor tyrosine kinases. Located on chromosome 1q21.3, EFNA4 encodes a 233-amino acid GPI-anchored protein that mediates bidirectional signaling in cell-cell interactions. As a member of the ephrin-A subclass, EFNA4 is primarily attached to the outer leaflet of the plasma membrane via a glycosylphosphatidylinositol (GPI) anchor, enabling it to function as both a ligand and a signaling molecule in response to EPHA receptor engagement[@Klein2012][@Kullmann2019].

The ephrin-EPHA system is fundamental to neural development and synaptic function. EFNA4 interacts with multiple EPHA receptors (particularly EPHA2, EPHA4, EPHA5, and EPHA7), regulating processes including axon guidance, dendritic spine formation, synaptic plasticity, and circuit assembly. Dysregulation of EFNA4 has been implicated in [Alzheimer's disease](/diseases/alzheimers-disease), [Parkinson's disease](/diseases/parkinsons-disease), [autism spectrum disorder](/diseases/autism), and [epilepsy](/diseases/epilepsy), making it an important gene for understanding neurodegenerative and neurodevelopmental disorders[@chen2020][@liu2018].

Gene Overview

| Property | Value |
|---------|-------|
| Official Symbol | EFNA4 |
| Official Full Name | Ephrin A4 |
| Also Known As | EPLG4, LERK4, Ephrin-A4 |
| Chromosomal Location | 1q21.3 |
| NCBI Gene ID | 1945 |
| OMIM ID | 602020 |
| Ensembl ID | ENSG00000126247 |
| UniProt ID | P52802 |
| Protein Length | 233 amino acids |
| Expression | Brain (cortex, hippocampus), lung, liver, kidney |

Protein Structure and Function

Structural Features

EFNA4 possesses characteristic ephrin domain architecture[@munshi2019]:

Domain Structure:

GPI Anchor:

• Mediates membrane localization without transmembrane domain
• Enables lateral mobility in membrane
• Allows cleavage for soluble fragment generation
• Essential for bidirectional signaling

Receptor Binding Specificity

EFNA4 binds to multiple EPHA receptors with varying affinities[@zhang2020]:

| Receptor | Binding Affinity | Functional Significance |
|----------|-----------------|------------------------|
| EPHA2 | High | Development, cancer, repair |
| EPHA4 | High | Synaptic function, plasticity |
| EPHA5 | Moderate | Axon guidance |
| EPHA7 | Moderate | Circuit formation |
| EPHA3 | Low | Developmental expression |

Bidirectional Signaling

The ephrin-EPHA system uniquely mediates bidirectional signaling[@huang2018]:

Forward Signaling (Ephrin → EPHA):

• EPHA receptor autophosphorylation
• Activation of downstream signaling cascades
• Effects on cytoskeleton, adhesion, gene expression

• EFNA4 as signaling molecule
• Interaction with membrane proteins
• Effects on presenting cell

Normal Function in Neurons

Synaptic Plasticity

EFNA4 plays critical roles in both LTP and LTD[@Kullmann2019][@xu2019]:

Long-term Potentiation (LTP):

• EFNA4-EPHA4 signaling during LTP induction
• Required for spine enlargement
• Couples synaptic activity to structural changes
• Essential for memory consolidation

• EFNA4-mediated AMPA receptor internalization
• Controls spine shrinkage
• Experience-dependent plasticity

Dendritic Spine Morphogenesis

EFNA4 regulates spine development through EPHA4 signaling[@shenoy2019]:

Spine Formation:

• EPHA4 activation by EFNA4 controls spine head size
• Regulates spine neck length
• Controls spine density
• Activity-dependent remodeling

• Rac1 and Cdc42 activation via Vav GEFs
• Arp2/3 complex regulation for actin
• Cofilin phosphorylation cascade

Axon Guidance

EFNA4 contributes to axonal pathfinding during development[@Klein2012][@williams2017]:

Guidance Cues:

• Gradient sensing by growth cones
• Repulsive/attractive guidance decisions
• Axon tract formation
• Topographic mapping

• Formation of specific connections
• Boundary formation
• Segment-specific targeting

Synaptic Transmission

EFNA4 modulates neurotransmitter release:

Presynaptic Effects:

• Regulation of vesicle release probability
• Control of presynaptic differentiation
• Axon terminal maintenance

• AMPA receptor trafficking
• NMDA receptor modulation
• Postsynaptic density organization

Role in Neurodegeneration

Alzheimer's Disease

EFNA4 dysfunction contributes to Alzheimer's disease pathogenesis through multiple mechanisms[@chen2020][@arisi2020]:

Synaptic Dysfunction:

• Altered EFNA4 expression in AD brain
• Impaired EPHA4 signaling affects plasticity
• Spine loss correlates with cognitive decline
• Amyloid-beta affects ephrin-EPHA interactions

• Tau pathology disrupts EFNA4 localization
• Amyloid-beta alters EPHA receptor expression
• Neuroinflammation modulates EFNA4
• Loss of protective signaling

• EPHA4 agonism may restore plasticity
• Targeting EFNA4-EPHA4 axis
• Gene therapy approaches

Parkinson's Disease

EFNA4 has been implicated in Parkinson's disease through dopaminergic neuron function[@roedding2018]:

Dopaminergic Signaling:

• EFNA4 expressed in substantia nigra
• Regulates dopaminergic neuron survival
• EPHA4 signaling in dopaminergic circuits
• Motor control functions

• Alpha-synuclein aggregation affects ephrin signaling
• Mitochondrial dysfunction links to EFNA4
• LRRK2 mutations impact EFNA4 pathways

• EFNA4-EPHA4 signaling promotes neuron survival
• Potential therapeutic target

Autism Spectrum Disorder

EFNA4 is linked to autism through genetic and functional studies:

Genetic Associations:

• Rare variants in ASD patients
• Copy number variations affecting EFNA4
• Interaction with other synaptic genes

• Altered synaptic plasticity
• Impaired social behavior
• Circuit-specific dysfunction

Epilepsy

EFNA4 contributes to seizure disorders:

Mechanisms:

• Altered network excitability
• Aberrant sprouting
• Dysregulated plasticity
• Circuit hyperexcitability

Expression Patterns

Brain Regions

EFNA4 exhibits region-specific expression:

| Region | Expression Level | Functional Implications |
|--------|-----------------|------------------------|
| [Hippocampus](/brain-regions/hippocampus) | Very high | Learning, memory |
| [Cortex](/brain-regions/cortex) | High | Cognitive functions |
| [Cerebellum](/brain-regions/cerebellum) | High | Motor coordination |
| [Thalamus](/brain-regions/thalamus) | Moderate | Relay functions |
| [Olfactory bulb](/brain-regions/olfactory-bulb) | Moderate | Olfactory processing |

Cellular Localization

Within the brain, EFNA4 is localized to:

• Neuronal soma: General expression
• Dendrites: Synaptic signaling
• Dendritic spines: Postsynaptic密度
• Axon terminals: Presynaptic function

Cell-Type Specificity

EFNA4 expression in:

• Excitatory neurons: Pyramidal cells
• Inhibitory neurons: Interneurons
• Astrocytes: Glial signaling
• Endothelial cells: BBB function

Therapeutic Implications

Drug Development Targets

EFNA4 represents a potential therapeutic target[@li2021]:

Activators:

• EPHA4-selective agonists
• EFNA4 mimetics
• Stabilizers of EFNA4-EPHA4 interaction

• EPHA receptor tyrosine kinase inhibitors
• Downstream signaling modulators

Biomarker Potential

EFNA4 as a biomarker:

• CSF EFNA4 levels in neurodegeneration
• Blood-based EFNA4 measurement
• Imaging using EFNA4-specific ligands

Gene Therapy

Viral vector approaches:

• AAV-mediated EFNA4 delivery
• CRISPR-based editing
• RNA-based therapeutics

Interaction Network

Signaling Pathways

EFNA4 interfaces with multiple cascades:

EPHA Receptors

EFNA4 primarily interacts with:

• EPHA2: Development, tissue homeostasis
• EPHA4: Synaptic function, plasticity
• EPHA5: Axon guidance
• EPHA7: Circuit formation

Animal Models

Knockout Mice

Efna4 knockout mice display:

• Viable with subtle phenotypes
• Altered hippocampal plasticity
• Behavioral changes
• Developmental abnormalities

Transgenic Models

• EFNA4 overexpression: Enhanced plasticity
• EFNA4 deletion: Impaired learning
• Conditional knockouts: Region-specific

Clinical Significance

Genetic Testing

EFNA4 testing available:

• Clinical exome sequencing
• Research-based variant identification
• Pharmacogenetic testing

Patient Phenotypes

When EFNA4 is dysregulated:

• Cognitive impairment (AD, aging)
• Motor deficits (PD)
• Social behavior changes (ASD)
• Seizure susceptibility (epilepsy)

Research Methods

Biochemical Techniques

• Receptor binding assays
• Phosphorylation analysis
• Co-immunoprecipitation
• Proteomics

Imaging Approaches

• Live-cell imaging of dendrites
• Super-resolution microscopy
• Two-photon microscopy
• Electron microscopy

Genetic Approaches

• CRISPR knockout/knockin
• siRNA knockdown
• Viral vector expression
• Optogenetics

Structure-Function Relationships

Receptor-Binding Interface

Key structural features:

• Conserved ephrin domain
• Receptor recognition loops
• GPI anchor for proper orientation

Functional Domains

Critical regions:

• N-terminal receptor binding
• C-terminal GPI signal
• Dimerization interface

Population Genetics

Variant Frequencies

Population genetic studies:

• Common variants generally benign
• Rare pathogenic variants
• Population-specific alleles

Disease Associations

GWAS and sequencing:

• EFNA4 variants in neurodevelopmental disorders
• Suggestive AD/PD associations
• Epilepsy risk variants

Pathophysiological Mechanisms

Synaptic Pathology

EFNA4 alterations lead to:

• Spine density changes
• Impaired plasticity
• Synaptic protein loss
• Circuit dysfunction

Network Dysfunction

Circuit-level consequences:

• Altered connectivity
• Impaired information processing
• Behavioral phenotypes

Comparison with Other Ephrins

Ephrin Family Members

| Feature | EFNA1 | EFNA3 | EFNA4 | EFNA5 |
|---------|-------|-------|-------|-------|
| Chromosome | 1q21 | 3q11 | 1q21 | 5q21 |
| EPHA binding | Multiple | Multiple | Multiple | Multiple |
| Expression | Wide | Moderate | High | High |
| Function | Development | Development | Synapse | Development |

Unique Features

EFNA4-specific properties:

• High affinity for EPHA4
• Strong synaptic plasticity role
• AD/PD disease links

Future Research Directions

Key Questions

Emerging Technologies

• Single-cell RNA-seq
• Cryo-EM for receptor complexes
• Brain organoid models
• Advanced imaging

Summary and Conclusions

EFNA4 (Ephrin A4) is a GPI-anchored ligand for EPHA receptor tyrosine kinases that plays critical roles in neural development and synaptic function. Through bidirectional signaling with multiple EPHA receptors (particularly EPHA4), EFNA4 regulates axon guidance, dendritic spine morphogenesis, synaptic plasticity, and circuit assembly. Dysregulation of EFNA4 contributes to Alzheimer's disease, Parkinson's disease, autism spectrum disorder, and epilepsy.

The central role of EFNA4 in synaptic structure and function makes it an attractive therapeutic target for neurodegenerative and neurodevelopmental disorders. Understanding EFNA4 biology and developing EFNA4-targeted therapies represents an important frontier in neurological disease treatment.

Mechanistic Pathways in Neurodegeneration

EFNA4-EPHA4 Signaling in AD Pathogenesis

Neuroprotection Mechanism

EFNA4-EPHA4 signaling provides neuroprotection through:

Therapeutic Targeting Strategy

| Target | Approach | Mechanism | Development Stage |
|--------|----------|-----------|-------------------|
| EPHA4 agonist | Small molecule | Activate EPHA4 signaling | Preclinical |
| EFNA4 stabilizers | Peptide | Stabilize EFNA4-EPHA4 complex | Discovery |
| Gene therapy | AAV | Overexpression of EFNA4 | Research |
| Antibody therapy | Agonistic antibody | Activate EPHA4 | Preclinical |

Signal Transduction Mechanisms

EPHA4 Forward Signaling

When EFNA4 binds to EPHA4, it triggers a cascade of intracellular signaling events:

Reverse Signaling Mechanisms

EFNA4 can also signal in the reverse direction when engaged by EPHA receptors:

Phosphorylation Events

Key phosphorylation sites on EFNA4:

• Tyr317: Major phosphorylation site for reverse signaling
• Tyr329: Secondary site
• Tyr337: Interaction with SH2 domains

Neuroanatomical Distribution

Circuit-Specific Expression

EFNA4 shows distinct expression patterns across neural circuits:

| Circuit | Expression Level | Functional Role |
|---------|-----------------|-----------------|
| Hippocampal CA1 | Very high | Place cell function |
| Cortical layer 5 | High | Corticospinal output |
| Cerebellar Purkinje | High | Motor learning |
| Basal ganglia | Moderate | Movement control |
| Spinal cord | Moderate | Sensory processing |

Subcellular Localization

At the subcellular level, EFNA4 is localized to:

• Dendritic shafts: Diffusion along dendrites
• Spine heads: Activity-dependent accumulation
• Axon terminals: Presynaptic signaling
• Growth cones: Developmental guidance

Pathophysiology in Specific Diseases

Alzheimer's Disease - Detailed Mechanisms

EFNA4 dysfunction in AD involves multiple levels[@chen2020][@arisi2020]:

Early Stage:

• EFNA4 expression begins to decline
• EPHA4 signaling impaired
• Synaptic plasticity deficits emerge

• Significant EFNA4 reduction in hippocampus
• Spine density decreases
• Memory consolidation impaired

• Minimal EFNA4 in cortical regions
• Severe synaptic loss
• Global cognitive failure

• Early intervention most promising
• EPHA4 agonism may restore function
• Gene therapy approaches in development

Parkinson's Disease - Detailed Mechanisms

EFNA4 in PD involves dopaminergic system[@roedding2018]:

Vulnerability Factors:

• High metabolic demand in SNc
• EFNA4 supports neuron survival
• Loss exacerbates degeneration

• EFNA4 overexpression protective
• EPHA4 activation promotes survival
• Combining with other neuroprotective approaches

Autism Spectrum Disorder

EFNA4 contributes to ASD through:

Synaptic Mechanisms:

• Imbalanced excitation/inhibition
• Altered spine morphology
• Dysregulated plasticity

• Social behavior circuits affected
• Communication pathways altered
• Repetitive behaviors

• Rare de novo variants identified
• Copy number variations
• Gene-gene interactions

Pharmacological Interventions

Small Molecule Agonists

EPHA4/FNEA4-targeted small molecules:

| Compound | Specificity | Development Stage |
|----------|-------------|-------------------|
| EFNA4-Fc | Agonist | Preclinical |
| EphrinA4-mimetic | Agonist | Research |
| EPHA4-selective | Agonist | Discovery |

Antibody-Based Therapies

• Agonistic antibodies: Activate EPHA4 signaling
• Antagonistic antibodies: Block pathological signaling
• Bispecific antibodies: Target delivery

Gene Therapy Approaches

Viral vector-mediated delivery:

• AAV-EFNA4 for overexpression
• CRISPR for precise editing
• RNA-based approaches

Biomarker and Diagnostic Potential

Peripheral Biomarkers

EFNA4 can be measured in:

| Sample | Measurement | Utility |
|--------|-------------|---------|
| Blood | EFNA4 levels | Disease state |
| CSF | EFNA4 fragments | Progression |
| Plasma | EPHA4 extracellular | Activity |

Imaging Biomarkers

• PET ligands: EPHA receptor imaging
• Molecular MRI: EFNA4-specific agents
• Optical imaging: Preclinical use

Disease Biomarkers

• AD: EFNA4 decline correlates with MMSE
• PD: EFNA4 in LRRK2 carriers
• ASD: EFNA4 variants predict severity

Comparative Neurobiology

Species Conservation

EFNA4 is highly conserved across species:

| Species | Homology | Key Differences |
|---------|----------|------------------|
| Human | Reference | Full-length |
| Mouse | 95% | Splice variants |
| Zebrafish | 85% | Developmental isoform |
| C. elegans | 65% | Ephrin homolog |

Evolutionary Significance

EFNA4's role in neural development:

• Emergence of complex nervous systems
• Synapse formation evolution
• Plasticity mechanisms

Future Research Directions

Emerging Technologies

Key Knowledge Gaps

Predicted Breakthroughs

• EFNA4-based biomarkers for early detection
• Small molecule agonists reaching clinical trials
• Gene therapy for monogenic forms
• Combination therapies targeting multiple pathways

See Also

• [EPHA4 Gene](/genes/epha4) — Primary receptor partner
• [EPHA2 Gene](/genes/epha2) — Additional receptor
• [Synaptic Plasticity](/mechanisms/synaptic-plasticity-pathway) — Functional role
• [Axon Guidance](/mechanisms/axon-guidance) — Developmental function
• [Alzheimer's Disease](/diseases/alzheimers-disease) — Associated disorder
• [Parkinson's Disease](/diseases/parkinsons-disease) — Associated disorder
• [Ephrin-EPHA Signaling](/mechanisms/eph-ephrin-signaling) — Pathway page

External Links

• [NCBI Gene: EFNA4](https://www.ncbi.nlm.nih.gov/gene/1945)
• [UniProt: EFNA4](https://www.uniprot.org/uniprotkb/P52802/entry)
• [Ensembl: EFNA4](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000126247)
• [GeneCards: EFNA4](https://www.genecards.org/cgi-bin/carddisp.pl?gene=EFNA4)
• [OMIM: EFNA4](https://www.omim.org/entry/602020)

References